William Blair restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report ...

William Blair reiterated their outperform rating on shares of Vital Farms (NASDAQ:VITL – Free Report) in a report published on Friday morning,RTT News reports. William Blair also issued estimates for ...

Equities researchers at William Blair increased their FY2026 EPS estimates for argenx in a research note issued on Friday, ...

William Blair restated their outperform rating on shares of Colliers International Group (NASDAQ:CIGI – Free Report) (TSE:CIGI) in a report published on Friday morning,RTT News reports. Other equities ...

Analysts at William Blair issued their Q1 2025 earnings per share estimates for First Solar in a note issued to investors on ...

William Blair restated their outperform rating on shares of Kezar Life Sciences (NASDAQ:KZR – Free Report) in a research report released on Friday, Marketbeat Ratings reports. Several other research ...

William Blair started coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note published on Friday, Marketbeat Ratings reports. The brokerage issued an outperform ...

William Blair issued their Q1 2026 earnings estimates for shares of Verve Therapeutics in a report issued on Thursday, ...

Investment analysts at William Blair boosted their Q3 2026 earnings per share (EPS) estimates for shares of Salesforce in a ...

We recently published a list of 8 Worst Performing Mutual Funds in 2024. In this article, we are going to take a look at ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform ...

Analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of MDxHealth in a research ...